NEW YORK (Reuters Health) – A multinational study has shown that progression-free survival in elderly patients with untreated metastatic colorectal cancer (CRC) is improved significantly when bevacizumab is…
NEW YORK (Reuters Health) – Elderly patients with unresected stage III non-small-cell lung cancer (NSCLC) who are not candidates for chemoradiotherapy benefit from radiation therapy (RT) alone, according…
NEW YORK (Reuters Health) – After resection of pancreatic adenocarcinoma, chemotherapy with fluorouracil or gemcitabine reduces mortality by about a third, Taiwanese researchers have shown. On the other…
NEW YORK (Reuters Health) – Impaired kidney function related to treatment of childhood cancer does not recover over time, according to a Dutch study reported in Cancer Epidemiology,…
The Women’s Health Initiative launched a hormone therapy trial in the 1990s and follow-up continued with the women participating in the trials. A new study describes the long-term…
By Will Boggs, MD NEW YORK (Reuters Health) – Port-A-Cath-related thrombosis develops in up to 40% of pediatric oncology patients, researchers from Switzerland report. “Children with cancer who…
What if it were possible to combine the technological capabilities of an entire laboratory on one single chip? Scientists all across Europe may be getting close. Scientists at…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
NEW YORK (Reuters Health) – After primary surgery for early-stage endometrial cancer, adjuvant external beam radiation therapy confers no survival benefit overall, according to a Norwegian study. In…
NEW YORK (Reuters Health) – Among several different DNA-based quantitative polymerase chain reaction (qPCR) assays for detecting a critical JAK2 mutation in myeloproliferative neoplasms, one stands out as…